Sign up to save your podcasts
Or
Share Bill Sasse: An Insider’s Account of the Alzheimer’s Solanezumab Drug Trial | Patient Perspectives
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Bill Sasse: An Insider’s Account of the Alzheimer’s Solanezumab Drug Trial | Patient Perspectives
The process of finding new treatments for Alzheimer’s disease is one of trial and error — and every “failed” trial generates invaluable new data to help researchers and drug developers understand what works, what doesn’t, and why. On Wednesday, January 24th, at 10:00 a.m. PT/1:00 p.m. ET, drug trial participant Bill Sasse, who was a participant in Eli Lilly’s clinical trial of experimental monoclonal antibody drug solanezumab, joins Being Patient Live Talks to discuss his experience with the drug trial. In March of 2023, solanezumab ultimately failed to hit its benchmarks in slowing cognitive decline and the trial was discontinued.
Sasse, whose father died of Alzheimer’s, had the unique experience of participating in a clinical trial for a MAB drug without having any symptoms of cognitive decline. An army veteran, retired business owner, grandparent, and a native of Columbus, Indiana, he joined the trial after being inspired by a documentary about Glen Campbell promoting the trial, asking himself, “Why not, me?”
With his wife as his trial partner, he participated in the solanezumab trial for eight years before it was announced that the clinical trial had failed. He has participated in panels with Eli Lilly on his experience with the trial.
Watch the full video to learn more about the clinical trial experience with MAB drugs.
_____
If you loved watching this Live Talk, visit our website to find more of our Alzheimer’s coverage and subscribe to our newsletter: https://www.beingpatient.com/
Follow Being Patient:
Twitter: https://twitter.com/Being_Patient_
Instagram: https://www.instagram.com/beingpatientvoices/
Facebook: https://www.facebook.com/beingpatientalzheimers
LinkedIn: https://www.linkedin.com/company/being-patient
Being Patient is an editorially independent journalism outlet for news and reporting about brain health, cognitive science, and neurodegenerative diseases. In our Live Talk series on Facebook, former Wall Street Journal Editor and founder of Being Patient, Deborah Kan, interviews brain health experts and people living with dementia.
Check out our latest Live Talks: https://www.beingpatient.com/category/video/
#alzheimersresearch #solanezumab #clinicaltrials #alzheimers #dementia
View all episodes
By Being Patient
4.6
99 ratings
The process of finding new treatments for Alzheimer’s disease is one of trial and error — and every “failed” trial generates invaluable new data to help researchers and drug developers understand what works, what doesn’t, and why. On Wednesday, January 24th, at 10:00 a.m. PT/1:00 p.m. ET, drug trial participant Bill Sasse, who was a participant in Eli Lilly’s clinical trial of experimental monoclonal antibody drug solanezumab, joins Being Patient Live Talks to discuss his experience with the drug trial. In March of 2023, solanezumab ultimately failed to hit its benchmarks in slowing cognitive decline and the trial was discontinued.
Sasse, whose father died of Alzheimer’s, had the unique experience of participating in a clinical trial for a MAB drug without having any symptoms of cognitive decline. An army veteran, retired business owner, grandparent, and a native of Columbus, Indiana, he joined the trial after being inspired by a documentary about Glen Campbell promoting the trial, asking himself, “Why not, me?”
With his wife as his trial partner, he participated in the solanezumab trial for eight years before it was announced that the clinical trial had failed. He has participated in panels with Eli Lilly on his experience with the trial.
Watch the full video to learn more about the clinical trial experience with MAB drugs.
_____
If you loved watching this Live Talk, visit our website to find more of our Alzheimer’s coverage and subscribe to our newsletter: https://www.beingpatient.com/
Follow Being Patient:
Twitter: https://twitter.com/Being_Patient_
Instagram: https://www.instagram.com/beingpatientvoices/
Facebook: https://www.facebook.com/beingpatientalzheimers
LinkedIn: https://www.linkedin.com/company/being-patient
Being Patient is an editorially independent journalism outlet for news and reporting about brain health, cognitive science, and neurodegenerative diseases. In our Live Talk series on Facebook, former Wall Street Journal Editor and founder of Being Patient, Deborah Kan, interviews brain health experts and people living with dementia.
Check out our latest Live Talks: https://www.beingpatient.com/category/video/
#alzheimersresearch #solanezumab #clinicaltrials #alzheimers #dementia
More shows like Brain Talk | Being Patient for Alzheimer's Patients and Caregivers
View all
The Human Upgrade: Biohacking for Longevity & Performance
7,201 Listeners
Retirement Answer Man
1,318 Listeners
10% Happier with Dan Harris
12,730 Listeners
The Energy Blueprint Podcast
703 Listeners
The mindbodygreen Podcast
2,038 Listeners
Dr. Berg’s Healthy Keto and Intermittent Fasting Podcast
1,681 Listeners
The Genius Life
4,913 Listeners
Dhru Purohit Show
3,530 Listeners
The Dr. Hyman Show
9,245 Listeners
The Peter Attia Drive
8,782 Listeners
Life Time Talks
142 Listeners
Chasing Life
8,185 Listeners
ZOE Science & Nutrition
2,061 Listeners
The Mel Robbins Podcast
20,347 Listeners
Truth, Lies & Alzheimer's
16 Listeners